DAPAGLIFLOZIN\METFORMIN: 92 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
92
Total FAERS Reports
22 (23.9%)
Deaths Reported
15
Hospitalizations
92
As Primary/Secondary Suspect
5
Life-Threatening
1
Disabilities
Active Ingredient: DAPAGLIFLOZIN\METFORMIN HYDROCHLORIDE ·
First Report: 20150101 · Latest Report: 20250816
What Are the Most Common DAPAGLIFLOZIN\METFORMIN Side Effects?
#1 Most Reported
Death
18 reports (19.6%)
#2 Most Reported
Basal cell carcinoma
8 reports (8.7%)
#3 Most Reported
Cerebrovascular accident
6 reports (6.5%)
All DAPAGLIFLOZIN\METFORMIN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 18 | 19.6% | 18 | 0 |
| Basal cell carcinoma | 8 | 8.7% | 0 | 0 |
| Blood glucose increased | 6 | 6.5% | 0 | 2 |
| Cerebrovascular accident | 6 | 6.5% | 0 | 1 |
| Blood glucose abnormal | 5 | 5.4% | 0 | 2 |
| Deafness | 5 | 5.4% | 0 | 0 |
Who Reports DAPAGLIFLOZIN\METFORMIN Side Effects? Age & Gender Data
Gender: 48.9% female, 51.1% male. Average age: 68.7 years. Most reports from: US. View detailed demographics →
Is DAPAGLIFLOZIN\METFORMIN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2015 | 4 | 0 | 0 |
| 2020 | 2 | 0 | 1 |
| 2022 | 1 | 0 | 0 |
| 2023 | 3 | 0 | 0 |
| 2024 | 3 | 0 | 2 |
| 2025 | 16 | 7 | 4 |
What Is DAPAGLIFLOZIN\METFORMIN Used For?
| Indication | Reports |
|---|---|
| Type 2 diabetes mellitus | 21 |
| Diabetes mellitus | 12 |
| Product used for unknown indication | 6 |
Official FDA Label for DAPAGLIFLOZIN\METFORMIN
Official prescribing information from the FDA-approved drug label.